These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD. Lioufas NM; Pascoe EM; Hawley CM; Elder GJ; Badve SV; Block GA; Johnson DW; Toussaint ND J Am Soc Nephrol; 2022 Jan; 33(1):59-76. PubMed ID: 34645696 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D. Hara T; Hijikata Y; Matsubara Y; Watanabe N Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877 [TBL] [Abstract][Full Text] [Related]
8. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease. Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430 [TBL] [Abstract][Full Text] [Related]
9. Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138 [TBL] [Abstract][Full Text] [Related]
10. Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Kaesler N; Goettsch C; Weis D; Schurgers L; Hellmann B; Floege J; Kramann R Nephrol Dial Transplant; 2020 Jan; 35(1):65-73. PubMed ID: 30715488 [TBL] [Abstract][Full Text] [Related]
11. Interventions for chronic kidney disease-associated restless legs syndrome. Gopaluni S; Sherif M; Ahmadouk NA Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010690. PubMed ID: 27819409 [TBL] [Abstract][Full Text] [Related]